Caribou Biosciences (CRBU) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free CRBU Stock Alerts $3.71 -0.05 (-1.33%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCaribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingglobenewswire.com - April 24 at 10:00 AMCaribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Valueseekingalpha.com - April 18 at 5:57 PMCaribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)globenewswire.com - April 15 at 9:00 AMVanguard Group Inc. Increases Stock Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - April 15 at 4:15 AMBuy Rating Affirmed: Caribou Biosciences’ Promising Trials and Strategic Market Positioningmarkets.businessinsider.com - April 8 at 12:17 PMKura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Sessionmsn.com - April 5 at 10:30 AMCaribou Biosciences, Inc.: Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupusfinanznachrichten.de - April 5 at 5:30 AMCaribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupusglobenewswire.com - April 4 at 4:00 PMShort Interest in Caribou Biosciences, Inc. (NASDAQ:CRBU) Increases By 7.2%marketbeat.com - April 2 at 7:16 AMWith 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big gunsfinance.yahoo.com - April 1 at 10:19 AMAssenagon Asset Management S.A. Has $12.94 Million Stock Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - March 29 at 5:16 AMCaribou Biosciences (NASDAQ:CRBU) Stock Price Up 6.5%marketbeat.com - March 25 at 1:35 PMQ1 2024 EPS Estimates for Caribou Biosciences, Inc. (NASDAQ:CRBU) Lifted by HC Wainwrightmarketbeat.com - March 21 at 8:03 AMCaribou Biosciences (NASDAQ:CRBU) Shares Gap Up After Analyst Upgrademarketbeat.com - March 19 at 11:48 AMCaribou Biosciences (NASDAQ:CRBU) Price Target Increased to $24.00 by Analysts at HC Wainwrightmarketbeat.com - March 19 at 8:34 AMFY2024 EPS Estimates for Caribou Biosciences, Inc. Decreased by Cantor Fitzgerald (NASDAQ:CRBU)marketbeat.com - March 18 at 2:04 AMCaribou Biosciences, Inc. to Post Q1 2024 Earnings of ($0.44) Per Share, Leerink Partnrs Forecasts (NASDAQ:CRBU)marketbeat.com - March 15 at 6:26 AMCRBU Oct 2024 5.000 putfinance.yahoo.com - March 14 at 11:53 PMCaribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry Pointmsn.com - March 14 at 6:52 PMQ1 2024 Earnings Estimate for Caribou Biosciences, Inc. Issued By Brookline Capital Management (NASDAQ:CRBU)marketbeat.com - March 14 at 6:40 AMOptimistic Outlook for Caribou Biosciences with a Buy Rating and $20 Price Targetmarkets.businessinsider.com - March 13 at 10:00 AMCaribou Biosciences, Inc. (NASDAQ:CRBU) Expected to Earn FY2028 Earnings of ($0.72) Per Sharemarketbeat.com - March 13 at 7:18 AMCaribou Biosciences Shares Fall on Wall Street Missmarketwatch.com - March 12 at 11:54 PMWhy Caribou Biosciences Stock Is Crashing Todayfool.com - March 12 at 12:37 PMCaribou Biosciences (NASDAQ:CRBU) Stock Price Down 18.4%marketbeat.com - March 12 at 12:12 PMCaribou Biosciences, Inc.: Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 12 at 8:53 AMCaribou Bioscience GAAP EPS of -$0.39 in-line, revenue of $3.56M misses by $1.05Mmsn.com - March 11 at 8:31 PMCaribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatemarkets.businessinsider.com - March 11 at 8:31 PMCaribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 11 at 4:05 PMCaribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - March 6 at 6:57 PM165,192 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Acquired by Laurion Capital Management LPmarketbeat.com - March 5 at 2:39 PMAlkeon Capital Management LLC Has $7.86 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - March 3 at 11:41 AMCRBU Oct 2024 2.500 callca.finance.yahoo.com - March 2 at 6:19 PMProfund Advisors LLC Takes $406,000 Position in Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - March 1 at 6:25 AMCitigroup Inc. Acquires 194,816 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - February 29 at 4:43 AMSteven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfoliofinance.yahoo.com - February 24 at 12:28 AMCRBU Mar 2024 7.500 putfinance.yahoo.com - February 23 at 7:27 PMCaribou Biosciences Stock (NASDAQ:CRBU), Short Interest Reportbenzinga.com - February 23 at 1:10 AMRafferty Asset Management LLC Purchases Shares of 507,400 Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - February 22 at 6:05 AMBarclays PLC Acquires 236,020 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - February 19 at 4:20 AMSilverarc Capital Management LLC Makes New Investment in Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - February 18 at 12:54 PMCaribou Biosciences to Participate in Upcoming Investor Conferencesglobenewswire.com - February 15 at 4:05 PMJump Financial LLC Takes Position in Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - February 11 at 4:41 AMCaribou Biosciences (NASDAQ:CRBU) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - February 7 at 10:10 AMCaribou Biosciences, Inc. (NASDAQ:CRBU) Shares Sold by Raymond James & Associatesmarketbeat.com - February 2 at 4:20 AMCaribou Biosciences: Under The Radar With Catalysts Approachingseekingalpha.com - February 1 at 12:42 PMAssenagon Asset Management S.A. Has $12.66 Million Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU)marketbeat.com - January 28 at 7:15 AM3 Biotech Stocks You Can Buy and Hold for the Next Decadefool.com - January 22 at 1:22 PMCaribou Biosciences, Inc. (NASDAQ:CRBU) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - January 22 at 2:14 AMRBC Capital Keeps Their Buy Rating on Caribou Biosciences (CRBU)markets.businessinsider.com - January 19 at 9:52 AM Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. CRBU Media Mentions By Week CRBU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBU News Sentiment▼-0.500.32▲Average Medical News Sentiment CRBU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBU Articles This Week▼22▲CRBU Articles Average Week Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aura Biosciences News Today Tenaya Therapeutics News Today TScan Therapeutics News Today Solid Biosciences News Today Adaptive Biotechnologies News Today Jasper Therapeutics News Today Tourmaline Bio News Today SOPHiA GENETICS News Today iTeos Therapeutics News Today Replimune Group News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRBU) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
